2013
DOI: 10.1074/jbc.m112.430801
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of PINK1 (PTEN-induced Putative Kinase 1) Mutations Associated with Parkinson Disease in Mammalian Cells and Drosophila*

Abstract: Background: Mutations in PINK1 cause recessive Parkinson disease. Results: PINK1 mutations in the kinase domain hamper Parkin translocation to mitochondria, and their analogous mutations in Drosophila cannot rescue PINK1-null phenotypes. Conclusion: PINK1 kinase activity is essential for its function and for regulating Parkin functions in mitochondria. Significance: Understanding the roles of PINK1 mutations will be helpful for deciphering the pathogenic mechanism of PINK1-linked Parkinson disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
42
2

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 67 publications
(46 citation statements)
references
References 74 publications
2
42
2
Order By: Relevance
“…4) but failed to undergo complete phosphorylation (Fig. 6) and inhibited Parkin recruitment and activation on depolarized mitochondria (17,47). We thus surmise that the principle functional defect of this mutant is in the process of PINK1 autophosphorylation or substrate recognition.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…4) but failed to undergo complete phosphorylation (Fig. 6) and inhibited Parkin recruitment and activation on depolarized mitochondria (17,47). We thus surmise that the principle functional defect of this mutant is in the process of PINK1 autophosphorylation or substrate recognition.…”
Section: Discussionmentioning
confidence: 97%
“…Constructs harboring the PINK1 KD mutation or one of 10 pathogenic mutations, including C92F, A168P, E240K, H271Q, G309D, L347P, G386A, G409V, E417G, and a pathogenic mutation that results in the insertion of glutamine at amino acid position 534 (referred to hereafter as 534insQ), were generated. These PINK1 mutants, with the exception of C92F, partially or completely impaired phosphorylation and inhibited Parkin recruitment onto depolarized mitochondria without altering mitochondrial localization (16,17,47). HeLa cells expressing PINK1-GFP harboring the aforementioned mutations were subjected to CN-PAGE following CCCP treatment.…”
Section: Development Of a Multicolor Detection Methods To Resolve A Himentioning
confidence: 99%
“…The UBL Domain Regulates Parkin Translocation to the Mitochondria-Parkin is cytoplasmic but translocates to the mitochondria upon activation by PINK1 (41,43). We sought to determine whether the UBL domain regulates the mitochondrial translocation of Parkin.…”
Section: Resultsmentioning
confidence: 99%
“…The accumulation of PINK1 in the outer membrane triggers recruitment of Parkin to the mitochondria and subsequent ubiquitination of Parkin substrates (38 -42). The ability of PINK1 to recruit Parkin to the mitochondria is absolutely dependent on its kinase activity (41,43). PINK1 phosphorylates Parkin at Ser-65 of the UBL domain (44).…”
mentioning
confidence: 99%
“…Upon mitochondrial damage, such as depolarization (Narendra et al, 2008), increased ROS production (Yang and Yang, 2013), activation of the mitochondrial unfolded protein response (mtUPR) (Jin and Youle, 2013) or expression of the short mitochondrial isoform of ARF (smARF, encoded by CDKN2A) (Grenier et al, 2014), PINK1 accumulates on the outer mitochondrial membrane and subsequently recruits the E3 ubiquitin ligase parkin to ubiquitylate outer mitochondrial membrane proteins (Matsuda et al, 2010;Narendra et al, 2010b;Sarraf et al, 2013;Vives-Bauza et al, 2010) (see poster). Parkinson's-disease-associated mutations in PINK1 and parkin disrupt their respective kinase and ubiquitylating activities (Lee et al, 2010a;Song et al, 2013;Sriram et al, 2005), leading to defective mitochondrial degradation. Depletion of DJ-1, another Parkinson's-disease-associated gene, disrupts both mitochondrial dynamics and morphology (Hao et al, 2010;Irrcher et al, 2010;Thomas et al, 2011).…”
Section: Dynamics Of Mitochondrial Degradation In Neurodegenerative Dmentioning
confidence: 99%